Advanced MedTech Announces Leadership Transition & Reports Record Revenues for FY2024
July 01, 2024 21:00 ET
|
Advanced MedTech
Singapore, July 02, 2024 (GLOBE NEWSWIRE) -- Abel Ang retires as Group Chief Executive Officer after a decade and will continue to serve on the Board of DirectorsAchieved record global revenues of...
NephroDI Therapeutics Announces Investment by Sound Bioventures to Accelerate Development of NDI-5001 as a Potential First-in-Class Therapy for Pediatric Orphan Kidney Disease
June 20, 2024 07:00 ET
|
NephroDI Therapeutics
New funding to take NDI-5001 into and through clinical proof of concept in Congenital Nephrogenic Diabetes Insipidus (NDI)New investment complements previously announced strategic corporate...
Sound Bioventures expands portfolio with new investment in US company NephroDI Therapeutics to accelerate development of NDI-5001 for pediatric orphan kidney disease
June 20, 2024 07:00 ET
|
Sound Bioventures
New funding will accelerate NephroDI’s asset, NDI-5001, into and through clinical proof of concept in Congenital Nephrogenic Diabetes Insipidus (NDI)New investment complements NephroDI’s previously...
Global Urology Laser Market Analysis Report 2024: Market Set to Surpass $1.8 Billion by 2031
May 31, 2024 04:03 ET
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Global Urology Laser Market Size, Share & Trends Analysis Report By Laser Type (Holmium Laser System, Thulium Laser System, Diode Laser System, and...
Global Urology Supplements Market Report 2024, Featuring Theralogix, Nature's Bounty, Solaray, Puritan's Pride, Schiff Nutrition, Biotexlife, MegaFood, Azo Health, Now Foods and Barleans
May 16, 2024 10:07 ET
|
Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Global Urology Supplements Market" report has been added to ResearchAndMarkets.com's offering.The global urology supplements market size was estimated...
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
May 07, 2024 06:30 ET
|
Teleflex Incorporated
WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024...
Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
May 01, 2024 06:30 ET
|
Teleflex Incorporated
Highlights include two head-to-head randomized clinical trials (RCT) data presentations of UroLift™ System vs. other modalities to treat benign prostatic hyperplasia (BPH) -Additional studies examine...
Global Urology Supplements Market Trends Analysis Report 2024-2030: Asia Pacific Emerges as Dominant Force, Multi-Ingredient Supplements Lead
April 30, 2024 05:36 ET
|
Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "Global Urology Supplements Market Size, Share & Trends Analysis Report by Type (Multi-ingredient, Single Ingredient), Application (Urinary Tract...
Global Portable Ultrasound Market Analysis Report 2024-2031: Use of Artificial Intelligence in Portable Ultrasound Devices and Emergence of Wearable Ultrasound Devices Gaining Momentum
April 18, 2024 07:23 ET
|
Research and Markets
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The "Portable Ultrasound Market by Product (POCUS, Handheld Ultrasound, Transducer, Gels), Technology (2D, 3D, 4D, Doppler), Display, Application (Breast...
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
April 02, 2024 06:30 ET
|
Teleflex Incorporated
WAYNE, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced...